IntelGenx Receives Health Canada Cannabis Micro-Processing License
SAINT LAURENT, Quebec, June 08, 2020 (GLOBE NEWSWIRE) — IntelGenx Corp. (TSX V:IGX)(OTCQB:IGXT) (the “Company” or “IntelGenx”), a leader in […]
NOVAGOLD Provides Comprehensive Response to Misleading and False Short-Seller Report
VANCOUVER, British Columbia, June 08, 2020 (GLOBE NEWSWIRE) — NOVAGOLD RESOURCES INC. (“NOVAGOLD” or the “Company”) (NYSE American, TSX: NG) today […]
Credicorp Announces Board Members Election and Expansion of the Board
Lima, June 08, 2020 (GLOBE NEWSWIRE) — Credicorp Ltd. announced in February 2020 a series of initiatives to bolster corporate governance to […]
NOVAGOLD Chairman Thomas S. Kaplan Addresses Misleading Short-and-Distort Report by Short Seller
VANCOUVER, British Columbia, June 08, 2020 (GLOBE NEWSWIRE) — NOVAGOLD RESOURCES INC. (“NOVAGOLD” or the “Company”) (NYSE American, TSX: NG) today […]
InspireMD, Inc. Announces Underwriter Exercise of Over-Allotment Option in Full and Closing of $11.5 Million Follow-On Underwritten Public Offering
TEL AVIV, Israel, June 08, 2020 (GLOBE NEWSWIRE) — InspireMD, Inc. (NYSE American: NSPR), the developer of the CGuard™ Embolic Prevention […]
Inspire Medical Systems, Inc. Announces Appointment of Medical Technology Industry Veteran Phil Ebeling as Chief Operating Officer
MINNEAPOLIS, June 08, 2020 (GLOBE NEWSWIRE) — Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire”), a medical technology company focused on […]
Icanic Brands Shareholders Agree to Voluntary Lockup of 69 Million Shares Until December 31, 2021
VANCOUVER, British Columbia, June 08, 2020 (GLOBE NEWSWIRE) — Icanic Brands Company, Inc. (CSE: ICAN, OTCQB: ICNAF) (“Icanic Brands” or […]
Avadel Pharmaceuticals to Present at BIO Digital
DUBLIN, Ireland, June 08, 2020 (GLOBE NEWSWIRE) — Avadel Pharmaceuticals plc (Nasdaq: AVDL) a company focused on developing FT218, an investigational, […]
Esperion to Participate in Fireside Chat at the Goldman Sachs 41st Annual Global Healthcare Conference
ANN ARBOR, Mich., June 08, 2020 (GLOBE NEWSWIRE) — Esperion (NASDAQ: ESPR) today announced that president and chief executive officer, […]
X4 Pharmaceuticals to Host Conference Call and Webcast to Discuss New Phase 2 Clinical Data for Mavorixafor in WHIM Syndrome to be Presented at 25ᵗʰ European Hematology Association Annual Congress
CAMBRIDGE, Mass., June 08, 2020 (GLOBE NEWSWIRE) — X4 Pharmaceuticals, Inc. (Nasdaq: XFOR), a leader in the discovery and development […]
